COVID-19’s Impact on Biopharma Mergers & Acquisitions in 2020
Felicia Rodriguez
January 7, 2021
Most reports indicate that 2020 was not a particularly good year for mergers and acquisitions (M&As) in the biopharma industry. There’s also some disagreement on numbers which can be related to how they are defining sectors; healthcare versus biotech and pharmaceutical, for example. Here’s a